Research Article
BibTex RIS Cite

continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome

Year 1992, Volume: 5 Issue: 2, 63 - 66, 01.04.1992

L. Sağlamer H. Öz S. Çalışkan A. Ekinci L. Uıukutlu L. Sever İ. Yıldız B. Aykaç

Abstract

Acute tumor lysis syndrome and associated renal failure are frequently seen in children with B cell leukemia and lymphoma. In patients resistant to conservative management, renal replacement therapy is required. Continuous arteriovenous hémodiafiltration (CAVHD) and continuous arteriovenous hemofiltration (CAVH) were used successfully in the treatment of tumor lysis syndrome and renal failure preceding chemotherapy in a child with B cell leukemia. The advantages of the methods are discussed.

Keywords

Continuous arteriovenous hemofiltration continuous arteriovenous hémodiafiltration B cell leukemia B cell lymphoma tumor lysis syndrome

References

  • Cadman EC. Lundberg WB, Bertlno JR. Hyperphos phatemla and hypocalcemia accompanying rapid cell lysis In a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977; 62:283-290.

Year 1992, Volume: 5 Issue: 2, 63 - 66, 01.04.1992

L. Sağlamer H. Öz S. Çalışkan A. Ekinci L. Uıukutlu L. Sever İ. Yıldız B. Aykaç

Abstract

References

  • Cadman EC. Lundberg WB, Bertlno JR. Hyperphos phatemla and hypocalcemia accompanying rapid cell lysis In a patient with Burkitt's lymphoma and Burkitt cell leukemia. Am J Med 1977; 62:283-290.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Reviews
Authors

L. Sağlamer This is me

H. Öz This is me

S. Çalışkan This is me

A. Ekinci This is me

L. Uıukutlu This is me

L. Sever This is me

İ. Yıldız This is me

B. Aykaç This is me

Publication Date April 1, 1992
Published in Issue Year 1992 Volume: 5 Issue: 2

Cite

APA Sağlamer, L., Öz, H., Çalışkan, S., Ekinci, A., et al. (1992). continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal, 5(2), 63-66.
AMA Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. April 1992;5(2):63-66.
Chicago Sağlamer, L., H. Öz, S. Çalışkan, A. Ekinci, L. Uıukutlu, L. Sever, İ. Yıldız, and B. Aykaç. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5, no. 2 (April 1992): 63-66.
EndNote Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B (April 1, 1992) continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Medical Journal 5 2 63–66.
IEEE L. Sağlamer, “continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome”, Marmara Med J, vol. 5, no. 2, pp. 63–66, 1992.
ISNAD Sağlamer, L. et al. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal 5/2 (April 1992), 63-66.
JAMA Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5:63–66.
MLA Sağlamer, L. et al. “Continuous Arteriovenous Hemodiafiltration and Hemofiltration in the Treatment of Tumor Lysis Syndrome”. Marmara Medical Journal, vol. 5, no. 2, 1992, pp. 63-66.
Vancouver Sağlamer L, Öz H, Çalışkan S, Ekinci A, Uıukutlu L, Sever L, Yıldız İ, Aykaç B. continuous arteriovenous hemodiafiltration and hemofiltration in the treatment of tumor lysis syndrome. Marmara Med J. 1992;5(2):63-6.